InspireMD, Inc.
NSPR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $177,055 | $115,779 | $134,484 | $128,580 |
| - Cash | $63,403 | $11,509 | $12,383 | $18,916 |
| + Debt | $2,367 | $3,424 | $2,322 | $2,338 |
| Enterprise Value | $116,019 | $107,694 | $124,423 | $112,002 |
| Revenue | $2,523 | $1,778 | $1,529 | $1,949 |
| % Growth | 41.9% | 16.3% | -21.5% | – |
| Gross Profit | $864 | $313 | $292 | $469 |
| % Margin | 34.2% | 17.6% | 19.1% | 24.1% |
| EBITDA | -$12,601 | -$12,912 | -$11,362 | -$9,292 |
| % Margin | -499.4% | -726.2% | -743.1% | -476.8% |
| Net Income | -$12,708 | -$13,151 | -$11,166 | -$9,174 |
| % Margin | -503.7% | -739.7% | -730.3% | -470.7% |
| EPS Diluted | -0.17 | -0.26 | -0.22 | -0.19 |
| % Growth | 34.6% | -18.2% | -15.8% | – |
| Operating Cash Flow | -$8,633 | -$8,333 | -$8,792 | -$6,750 |
| Capital Expenditures | -$329 | -$576 | -$359 | -$311 |
| Free Cash Flow | -$8,962 | -$8,909 | -$9,151 | -$7,061 |